Chairman since 2023

  • Born: 1966
  • Education: Master of Science in Business and Economics (M.Sc).
  • Experience: Lars Johansson has more than 29 years of experience from the Johnson & Johnson Group. He has a broad experience in sales and marketing as well as business management from both Medtech and pharmaceuticals. He has been CEO of Johnson & Johnson AB and Janssen Cilag AB. Lars Johansson has attended Michaël Berglund's training Professional Board work.
  • Other ongoing assignments: Board member of Schain Research AB, Mailo Global AB, MILA The bigger picture AB
  • Holdings: 244,009 shares.

Independent in relation to the Company and its management and the Company's major shareholders.

Annette Colin

Board member
Board member since May 2023

  • Born: 1965
  • Education: Business Administration at Lund University, Sweden.
  • Experience:Annette has more than 20 years of experience in executive positions such as CEO, CFO, COO, Group Financial Controller and Tax Manager, including more than 15 years in Life Science. Annette has worked in fast-growing companies and organizations and her broad skills include finance, strategic planning, capital raising, business development, leadership development, streamlining infrastructure and Investor Relations. She has been involved in several M&A and IPO transactions and her experience ranges from start-ups to Large Cap companies. She previously held leading positions at Boule Diagnostics AB (publ), Biotage AB (publ), Annexin Pharmaceuticals AB (publ), Observe Medical AB (publ), Stille AB (publ), Lindab International (publ), Perbio Science AB (publ, and EY
  • Other ongoing assignments: She is a board member of Initiator Pharma A/S (publ), Sozap AB (publ) and Colinex Capital AB. She has run her own consulting company, Colinex Capital AB, since 2008.
  • Holdings: No holdings.

Independent in relation to the Company and its management and the Company's major shareholders.


Board member
Board memeber of ProstaLund since 2012.

  • Born: 1945
  • Education: Trained physician and specialist in urology.
  • Experience: Sonny Schelin is a trained physician and specialist in general surgery and urology and has defended his thesis on microwave treatment of benign prostatic hyperplasia in Lund in 2006. Founder of the Specialist Medical Group in Kalmar and has extensive experience in prostate diseases and various treatment methods. Sonny Schelin is the inventor of PLFT,® Schelin Catheter®, CoreTherm® energy dosing and CoreFlow® Soft Stent and has further developed ProstaLund's treatment method to today's standards.
  • Other ongoing assignments: : CEO and board member of Schelin Medicin AB and Schelin Medicin Sweden AB. Deputy board member of Nordisk Medicin & Teknik AB.
  • Holdings: 2,713,579 shares.

Dependent in relation to the Company and its management and the Company's major shareholders, respectively.


Board member
Board member since 2020

  • Born: 1964
  • Education: Gothenburg School of Economics.
  • Experience: Solid experience in marketing and PR at national and international levels. She has many years of experience in board assignments by both listed and unlisted companies as well as associations. She also has valuable expertise from political work and lobbying at municipal, county and national levels. Deep knowledge of medical technology, pharmaceuticals and health care. After political work in the Swedish parliament, Marianne started a successful PR agency in 1994 that handled large national and international assignments such as crisis management, product launches, lobby campaigns, IPOs and brand campaigns. She and the agency have received several awards for, among other things, attitude campaigns in health.
  • Other ongoing assignments:Peptonic Medical AB (publ), 1.6 million club AB, First Communication AB and Effektiv Media i Stockholm Aktiebolag.
  • Holdings: 67,000 shares.

Independent in relation to the Company and its management and the Company's major shareholders.